Zacks Investment Research on MSN
Teva's Prolia biosimilar gets FDA nod, Xolair filing accepted
Teva Pharmaceutical Industries Ltd. TEVA announced that the FDA has approved its biosimilar to Amgen’s AMGN blockbuster drug, ...
On March 30, 2026, the FDA approved Ponlimsi, a biosimilar to Prolia, and is reviewing a biosimilar candidate for Xolair.
Pharmaceutical Technology on MSN
Teva receives FDA approval for Prolia biosimilar
The FDA approval for Ponlimsi is based on comprehensive evidence, including analytical and clinical data.
European regulators recommended a subcutaneous formulation for a key anti-CD38 therapy, offering clinicians and patients more flexible administration options for multiple myeloma.
ZIBO CITY, SHANDONG PROVINCE, CHINA, March 5, 2026 /EINPresswire.com/ — The global veterinary pharmaceuticals market has maintained steady growth in recent years ...
Like many doctors, I often encountered patients suffering from musculoskeletal pain who had tried a variety of allopathic and natural treatment modalities with limited or no success. In many cases, I ...
ProPublica is a nonprofit newsroom that investigates abuses of power. Sign up for Dispatches, a newsletter that spotlights wrongdoing around the country, to receive our stories in your inbox every ...
A woman was arrested for allegedly giving facial injections without a license in Miami following an undercover operation at her office, authorities said. Mayling Maya-Giraldo, 31, was arrested ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results